Ácido tranexámico: una alternativa terapéutica en pacientes con síndrome de HELLP / Tranexamic acid: A therapeutic alternative in patients with HELLP syndrome

Resumen OBJETIVO Evaluar si la prescripción de ácido tranexámico a pacientes con síndrome de HELLP mejora su curso clínico en forma general. MATERIALES Y MÉTODOS Estudio retrospectivo, analítico y comparativo al que se incluyeron dos grupos de pacientes con diagnóstico de síndrome de HELLP atendidas entre enero de 2015 y diciembre de 2016 en el servicio de Ginecología y Obstetricia del Hospital Universitario de Saltillo. A un grupo se le indicó ácido tranexámico y al control ningún medicamento. RESULTADOS Se incluyeron 18 pacientes, 9 en cada grupo. Parámetros de laboratorio: plaquetas mayores a 105 vs menores a 105 en el grupo control. La deshidrogenasa láctica (DHL) tuvo un decremento de 58 vs 16% en las pacientes tratadas en las primeras 48 horas. La aspartato aminotransferasa (TGO) mejoró 56 vs 43% en el grupo control y la alanina aminotransferasa (TGP) mejoró 31 vs 20% en el grupo control, ambas en las primeras 24 horas. La cuantificación de proteínas en orina en 24 horas reportó 2867 mg versus 3378 mg en el grupo control. La hemoglobina permaneció siempre en cifras superiores a 11 vs 9.92 g/dL del grupo control. Los días de estancia en la unidad de cuidados intensivos fue de 3 vs 4.16 del grupo control. CONCLUSIONES Hacen falta más estudios con asignación al azar, con una muestra más amplia, para valorar las ventajas y efectos del ácido tranexámico en pacientes con síndrome de HELLP. La prescripción de este medicamento representa una alternativa en el tratamiento del síndrome de HELLP, que proporciona un beneficio clínico.

Abstract OBJECTIVE To stablish if the use of tranexamic acid (TXA) in patients with HELLP syndrome improves the clinic curse in general terms. MATERIALS AND METHODS Analytic, comparative and retrospective study where two groups of patients are included, which assisted to the obstetrics and gynecology service in the Hospital Universitario de Saltillo, where the diagnosis of HELLP syndrome was made. Tranexamic acid was given to one of the groups versus the control group without the drug. RESULTS 18 patients were included, 9 in each group. The following was observed respect to the laboratory parameters: platelets greater than 105 vs smaller than 105 in the control group. The lactate dehydrogenase (DHL) had a decrease of 58 vs 16% in the patients without tranexamic acid in the first 48 hours. The aspartate aminotransferase (AST) improved 56 vs 43% in the control group, and the alanine aminotransferase (ALT) improved 31 vs 20% in the control group, both in the first 24 hours. The report of protein quantification in 24 hours was 2867 vs 3378 mg in the control group. The hemoglobin figures remained greater than 11vs 9.92 g/dL of the control group. The days of stay in the intensive care unit (UCI) were 3 vs 4.16 of the control group. CONCLUSIONS: Randomized studies are required with an extended sample, to value the benefits and effects of the tranexamic acid, in this kind of patients. According to the collected data the use of tranexamic acid represents an alternative in the treatment of HELLP syndrome, which provides a clinic benefit.

Acretismo placentario con abordaje predictivo y preventivo de hemorragia obstétrica / Placental accreta with predictive and preventive approach to obstetric hemorrhage

Resumen OBJETIVO Exponer el tratamiento médico y quirúrgico indicado en el Hospital Universitario de Saltillo a pacientes con acretismo placentario. MATERIALES Y MÉTODOS Estudio retrospectivo, transversal y analítico efectuado en pacientes tratadas con enfoque predictivo y preventivo de hemorragia obstétrica atendidas entre los años 2015-2017. Se incluyeron todas las pacientes operadas con la técnica descrita. Se analizan las variables maternas y fetales posquirúrgicas que aportan información para evaluar los resultados obstétricos mediante medias y porcentajes. RESULTADOS Se incluyeron 10 pacientes con media de edad de 31 años, 70% con antecedente de cesárea y 50% de legrado. El sangrado transquirúrgico tuvo una media de 1067 cc, con un tiempo quirúrgico promedio de 3.6 h, la media de transfusión de concentrados eritrocitarios fue de 2.3, el Apgar de los recién nacidos se reportó en ≥ 7, no se requirió reinternvención y no se encontraron casos de muerte materna. CONCLUSIONES Si bien el tamaño de la muestra es pequeño continuaremos recabando datos de lo sucedido con otras pacientes. Es indispensable estudiar más casos para tener evidencias de nuestra propuesta de tratamiento con pruebas aún más sólidas. También hace falta un seguimiento prolongado a las pacientes para conocer si hay o no complicaciones tardías.

Abstract OBJECTIVE Expose the medical and surgical treatment indicated in the University Hospital of Saltillo to patients with placental accreta. MATERIAL AND METHODS A retrospective, cross-sectional and analytical study, patients treated with a predictive and preventive approach of obstetric hemorrhage were studied in Hospital Universitario de Saltillo during 2015-2017. RESULTS 10 patients were included, with a mean age of 31 years, 70% had a history of cesarean section and 50% curettage. Transurgical bleeding averaged 1067 cc, an average surgical time of 3.6 hrs, average of transfusion of erythrocyte concentrates was 2.3, Apgar of newborns was reported ≥7, no surgical reoperation was required, no cases were found of maternal death. CONCLUSIONS Although the size of the sample is small, we will continue to collect data on what happened with other patients. It is essential to study more cases to have evidence of our treatment proposal with even more solid evidence. There is also a need for prolonged follow-up of patients to determine whether there are late complications or not.

[Cervical ectopic pregnancy of 16 weeks gestation. Block with preventive hysterectomy surgical technique for massive pelvic hemorrhage. Case report]. / Embarazo ectópico cervical de 16 semanas de gestación. Histerectomía en bloque con técnica quirúrgica preventiva para hemorragia pélvica masiva. Reporte de un caso.

Obstetric hemorrhage remains the leading cause of maternal death, we continue to insist on preventive management of patients at high risk of massive pelvic bleeding, uterine dearterialization selective, significantly reduces the morbidity and mortality of the patient, on this ocassion we report the case of a 33-year-old with a diagnosis of cervical ectopic pregnancy of 13 gestational weeks, treated with selective dearterialization of hypogastric arteries with excellent results, without postoperative complications.

[Hypogastric arteries ligation: an experience in gynecological and obstetric patients at Hospital Universitario de Saltillo]. / Experiencia en la ligadura de arterias hipogástricas a pacientes ginecológicas y obstétricas del Hospital Universitario de Saltillo.

BACKGROUND: Pelvic hemorrhage is a potential complication that occurs performing an obstetric or gynecological surgery, it is essential to know the distribution of pelvic vascular supplement, and implement preventive measures, can significantly reduce morbidity and mortality. OBJECTIVE: To describe the experience of hypogastric artery ligation, as a preventive and therapeutic measure of pelvic hemorrhage, this will give us new prospective lines for future investigation. METHODS: Retrospective observational study, in which all patient who were performed a surgical procedure and report hypogastric artery ligation at the Saltillo University Hospital, from January 2008 to July 2014 was studied. RESULTS: 41 patients were obtained with hypogastric artery ligation, 28 gynecological and 13 obstetric patients. Among gynecological indications, cancer surgery represents 67.85%, benign lesions 25% and pelvic abscess 7.12%. Obstetric indications were uterine hypotonia with 46%, placenta previa with 23.07% and uterine fibroids, broad ligament hematoma and abruptio placenta a total of 30.7%. There was one complication in relation with technique that was a laceration of internal iliac artery without any consequence linked to this. And uterine preserving of 62% was observed in obstetric patients. CONCLUSIONS: This technique is a feasible and safe for preventive and therapeutic management of pelvic surgery, with a low incidence of complications 3.5% in gynecological patients and 0% in obstetric, with a mortality of 0%.

[Anterior pelvic exenteration. Report of a case]. / Exenteración pelvica anterior. Reporte de un caso.

Anterior pelvic exenteration is the last opportunity to control disease in a patient with cervical cancer in an advanced stage with a vesico-vaginal fistula, or in a patient with persistence of the disease and the need of improving the quality of life. In this case we present the cause of a 62 year old patient, with IVa stage cervical cancer, with bladder spread and a vesico-vaginal fistula treated with an anterior pelvic exenteration with Bricker technique and adjuvant treatment with radiotherapy.